The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I trial of TAS-102 and concurrent radiation therapy for patients with locally recurrent, unresectable or metastatic, rectal cancer.
 
Joleen Marie Hubbard
Consulting or Advisory Role - Genentech/Roche (Inst)
Research Funding - Bayer (Inst); Boston Biomedical (Inst); Merck (Inst); Senhwa Biosciences (Inst); Taiho Pharmaceutical (Inst)
 
Alexis Diane Leal
Research Funding - Aduro Biotech (Inst); Bristol-Myers Squibb (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Aduro Biotech; Array BioPharma; Ipsen
 
Christopher Leigh Hallemeier
No Relationships to Disclose
 
Daniel H. Ahn
Consulting or Advisory Role - Astellas Pharma; Cardinal Health; Celltrion (I); Eisai; Merrimack; Paradigm
 
Nitin Mishra
No Relationships to Disclose
 
Nathan R. Foster
No Relationships to Disclose
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Celgene; Genentech/Roche; Glenmark; Ipsen (Inst); Lilly; Lilly; Merrimack; NCCN; Regeneron; Research to Practice
Research Funding - NCCN; NCI; Oncolytics
Expert Testimony - Helsinn Therapeutics
Other Relationship - ARMO BioSciences; Exelixis; Exelixis; Merck; Polaris; Sillajen
 
Axel Grothey
Consulting or Advisory Role - Amgen (Inst); Array BioPharma (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Guardant Health (Inst); Lilly (Inst)
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Eisai (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche; Merck Sharp & Dohme